Feasibility and safety of granulocytapheresis in Crohn's disease: A prospective cohort study

Gastroentérologie Clinique et Biologique - Tập 34 - Trang 682-686 - 2010
G. Bresci1, A. Romano1, A. Mazzoni2, F. Scatena2, E. Altomare3, A. Capria1, R. Sacco1,3
1U.O. di Gastroenterologia e Malattie Ricambio, Azienda Ospedaliera-Universitaria Pisana, A. Della Spina, 11, 56124 Pisa, Italy
2U.O. di Immunoematologia, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy
3Istituto di Medicina Interna, Universita’ di Foggia, Italy

Tài liệu tham khảo

Sloan, 1950, Life histories of patients with chronic ulcerative colitis: a review of 2000 cases, Gastroenterology, 16, 25, 10.1016/S0016-5085(19)36591-6

Mekhjìan, 1979, Clinical features and natural history of Crohn's disease, Gastroenterology, 77, 898, 10.1016/0016-5085(79)90389-5

Farmer, 1985, Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis, Gastroenterology, 88, 1818, 10.1016/0016-5085(85)90006-X

Bresci, 1997, Evaluation of clinical patterns in ulcerative colitis. A long-term follow-up, Int J Clin Pharmacol Res, 17, 17

Bresci, 2002, Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up, Dig Liver Dis, 34, 419, 10.1016/S1590-8658(02)80039-1

Summers, 1979, National cooperative Crohn's disease study: results of drug treatment, Gastroenterology, 77, 847, 10.1016/0016-5085(79)90385-8

Riis, 1973, The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year, Scand J Gastroentrol, 8, 71, 10.1080/00365521.1973.12096672

Ardizzone, 1999, Is maintenance therapy always necessary for patients with ulcerative colitis in remission?, Aliment Pharmacol Ther, 13, 373, 10.1046/j.1365-2036.1999.00473.x

Fregan, 2004, Editorial: 5ASA therapy for active Crohn's disease old friends, old data and new conclusion, Clin Gastroenterol Hepatol, 2, 376, 10.1016/S1542-3565(04)00121-1

Dignass, 2010, The second European evidence-based consensus on the diagnosis and managenet of Crohn's disease:current managemet, Journal Crohn's Colitis, 4, 28, 10.1016/j.crohns.2009.12.002

Yamaji, 1998, Current therapeutic apheresis technologies for inflammatory bowel disease, Ther Apher, 2, 105, 10.1111/j.1744-9987.1998.tb00085.x

Kawamura, 1999, New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease, Ther Apher, 3, 334, 10.1046/j.1526-0968.1999.00207.x

Kohgo, 2003, Leukocytapheresis for treatment of IBD, J Gastroenterol, 38, 51

Sawada, 2003, Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column, Curr Pharm Des, 9, 307, 10.2174/1381612033391928

Saniabadi, 2003, Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes, Therap Apher Dial, 7, 48, 10.1046/j.1526-0968.2003.00012.x

Suzuki, 2004, Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study, Dig Dis Sci, 49, 565, 10.1023/B:DDAS.0000026299.43792.ae

Best, 1976, Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study, Gastroenterology, 70, 439, 10.1016/S0016-5085(76)80163-1

Sandborn, 2002, A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease, Gastroenterology, 122, 512, 10.1053/gast.2002.31072

Satsangi, 2006, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, 55, 749, 10.1136/gut.2005.082909

Present, 2000, How to do without steroids in inflammatoy bowel disease, Inflamm Bowel Dis, 6, 48, 10.1002/ibd.3780060110

Carter MJ, Lobo AJ, Travis SP. IBD Section. British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53(Suppl. 5):V1-16.

Kozarek, 1995, Cyclosporin A in the precolectomy chronic ulcerative colitis patient: a community experience and its relationship to prospective and controlled clinical trials, Am J Gastroenterol, 90, 2093

Su, 2004, Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine, Gastroenterol Clin North Am, 33, 209, 10.1016/j.gtc.2004.02.004

Gordon, 2005, Inflammatory bowel disease-insights into pathogenesis and future therapeutic target, 19

Brannigan, 2000, Neutrophil apoptosis is delayed in patients with inflammatory bowel disease, Shock, 13, 361, 10.1097/00024382-200005000-00003

Lee, 1993, Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators, J Leukoc Biol, 54, 283, 10.1002/jlb.54.4.283

D’Odorico, 2000, Influence of disease site and activity on peripheral neutrophil function in inflammatory bowel disease, Dig Dis Sci, 45, 1594, 10.1023/A:1005521212948

Nikolaus, 1998, Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation, Gut, 42, 470, 10.1136/gut.42.4.470

Thông tin
Thông tin xuất bản

Gastroentérologie Clinique et Biologique

Tập 34

682-686

Thông tin tác giả